Keywords: elan, 3rd-qtr, product, revenues, soar, dublin, ireland-based
Elan's 3rd-qtr product revenues soar 51%
Article | 20 October 2000
Dublin, Ireland-based drugmaker Elan Corp has reported net income of$153.8 million for the third quarter of 2000, compared with $90.4 million in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
